Linderane

CAS No. 13476-25-0

Linderane( Linderane | )

Catalog No. M17966 CAS No. 13476-25-0

Linderane was characterized as a mechanism-based inactivator of CYP2C9.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 38 In Stock
10MG 61 In Stock
25MG 123 In Stock
50MG 179 In Stock
100MG 267 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Linderane
  • Note
    Research use only, not for human use.
  • Brief Description
    Linderane was characterized as a mechanism-based inactivator of CYP2C9.
  • Description
    Linderane is a cytochrome P450 2C9 inhibitor from Lindera aggregata (Sims).
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Linderane |
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    CYP2C9
  • Research Area
    Others-Field
  • Indication
    ——

Chemical Information

  • CAS Number
    13476-25-0
  • Formula Weight
    260.28
  • Molecular Formula
    C15H16O4
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 100 mg/mL (384.19 mM)
  • SMILES
    CC1=CCCC23C(O2)C(C4=C(C1)OC=C4C)OC3=O
  • Chemical Name
    (10S,10aS,E)-5,9-dimethyl-3,6,10,10a-tetrahydro-2H-10,1a-(epoxymethano)oxireno[2',3':4,5]cyclodeca[1,2-b]furan-12-one

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Levofloxacin N-oxide

    Levofloxacin N-oxide is an impurity isolated from levofloxacin.

  • IPSU

    IPSU is an antagonist of OX2 receptor. IPSU Exhibits approximately six-fold selectivity for OX2 versus OX1 receptors.

  • Deferitazole

    Deferitazole (FBS 0701) is a novel and orally active, selective and high affinity iron chelator.